首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study
【24h】

Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

机译:Xiyanping注射液(Andrographolide磺酸盐)的成本效果分析治疗成人群落肺炎:回顾性,倾向分数匹配队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Xiyanping injection (andrographolide sulfonate) has shown clinical effects on community acquired pneumonia. However, there is little known about the effectiveness and costs of combining Xiyanping injection with conventional treatment on adult community acquired pneumonia in daily practice. The aim of this study was to evaluate the cost-effectiveness of combining Xiyanping injection with conventional treatment for treatment of adult community acquired pneumonia by comparing with conventional treatment from a societal perspective. Using retrospective cohort method, this study demonstrates that Xiyanping injection combined with conventional treatment is superior to conventional treatment for patients using cephalosporins and antibiotics under the effectiveness index of length of hospital stay and is more cost-effective.
机译:Xiyanping注射(Androghrapholide磺酸盐)显示了对群落获得的肺炎的临床影响。 然而,关于将Xiyanping注射的有效性和成本与成人群落中的常规治疗相结合的有效性和成本毫无疑问。 本研究的目的是评估综合治疗综合治疗的成本效益,以通过与社会观点与常规治疗相比,对成人群落获得的肺炎。 本研究使用回顾性队列方法,表明Xiyanping注射与常规治疗相结合,优于使用头孢菌素和抗生素在医院住院长度的有效性指数下进行常规治疗,更具成本效益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号